Streetbeat News

Earnings

MRNA

Moderna Inc (NASDAQ:MRNA) reported Q4 2023 revenues of $2.81 billion from its COVID-19 vaccine, Spikevax, surpassing the $2.49 billion consensus. Despite a 43% Y/Y decline in net product sales to $2.8 billion due to lower sales volume, the company achieved a quarterly profit with an EPS of $0.55, beating the $(0.97) consensus. Moderna's market share in the U.S. retail segment for the COVID vaccine increased to 48% in fall 2023. The company also anticipates initial regulatory approvals for its RSV vaccine in the first half of 2024 and expects $4 billion in revenue from its respiratory franchise in 2024.

Portfolio Pulse from Vandana Singh

February 22, 2024 | 4:11 pm

NOVA

Sunnova Energy's shares dropped following the announcement of their Q4 financial results, which fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:09 pm

CNNE

Cannae Holdings, Inc. (CNNE) shares have seen an uptick following the announcement of its fourth-quarter financial results and a strategic partnership with JANA Partners. This development indicates a positive reception from the market, likely due to the potential growth and value addition from the partnership with JANA Partners, alongside strong Q4 performance.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:06 pm

FCN

FTI Consulting's shares surged following the announcement of their Q4 financial results, which exceeded expectations. Additionally, the company provided positive guidance for FY24, further boosting investor confidence.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:05 pm

RYI

Ryerson Holding Corporation's shares traded lower following the announcement of mixed financial results for the fourth quarter. The company's performance during this period did not fully meet market expectations, leading to a decrease in stock price.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:04 pm

ATNI

ATN International's stock is trading lower following the release of their Q4 financial results and future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:04 pm

RCUS

Arcus Biosciences' stock is trading higher following the announcement of mixed financial results for the fourth quarter.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:03 pm

YUM

Yum! Brands (NYSE:YUM), owner of KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill, is witnessing investor confidence growth despite an earnings miss on Feb. 7. The stock has seen a Golden Cross, indicating bullish sentiments, with a year-to-date increase of 3.5%. Wall Street analysts maintain an Overweight rating with a target of $144.35. The company aims for significant expansion milestones in 2024.

Portfolio Pulse from Surbhi Jain

February 22, 2024 | 4:02 pm

TK

Teekay Corporation's stock (TK) is trading lower following the announcement of a year-over-year decline in its Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:02 pm

TNDM

Tandem Diabetes Care's stock is experiencing increased trading activity and volatility following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:01 pm